You are currently viewing the summary.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Summary
The United States is preparing to modernize the rules that govern inventions in agricultural biotechnology, according to a White House memo released last week. The multiyear review process will clarify the roles of the agencies that determine the safety of genetically altered plants and animals: the Food and Drug Administration, the U.S. Department of Agriculture, and the Environmental Protection Agency. The current framework—last updated in 1992—didn't anticipate precise gene-editing methods, such as CRISPR, which some argue don't require the same review as traditional genetic engineering. Meanwhile, new techniques for genetic modification have sidestepped the approval process under the current framework, and many hope the White House initiative will clarify exactly what products need regulating.
